When that potential first big customer drops in your lap, how do you make the most of it? For an early-stage healthcare company, it’s about balancing the time commitment against the actual ROI, said Jean-Luc Neptune (@jeanlucneptune), executive director at Blueprint Health (@bphealth). Neptune is one of four speakers who’ll discuss the challenges of modern […]
Hard truth: Even the most promising startups are one calamity away from completely shutting down. Self-inflicted wounds are hard to escape from. But there are increasingly a number of options when a competitor, customer or would-be investor puts a company on the brink. Lee Ducker, one of the founders of Lake Whillans, sees the horror […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Do you want control? Or do you want to win? It’s a decision many entrepreneurs have to make early on, and the answer often determines what problems startups will have down the road, said Fahd Riaz, a partner at the law firm DLA Piper. Riaz is one of four panelists taking the stage at MedCity […]
Hey startup CEO: How will you need to think differently about protecting your assets in a way that allows you to build value in the long term?
There are plenty of good investors out there, but many will pull a Mr. Hyde act to get what they want from healthcare entrepreneurs.
It's time to know more about corporate venture capital because, unlike traditional venture or angel groups, there's much less insight on corporate VCs and their practices.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
We all want the 12x, but what happens when you're the 1x - and how do you make sure nothing goes wrong?
Through litigation finance, CFOs can manage a dormant asset: potential litigation.
Last week I discussed how emerging and innovative businesses can use distressed venture funding and litigation finance to protect their assets when legal action is needed. This week I am going to begin a dialogue regarding the efficiency of using litigation finance and distressed venture funding to cover legal fees and expenses as well as […]
Last week, I discussed the changing landscape of medtech innovation, and how shifting dynamics in the capital raising process have led young businesses to be more vulnerable to unscrupulous partners and mal-intentioned competitors. This week I will begin discussing how distressed venture funding and litigation finance can be used to help protect these innovating young […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Unfortunately, it is not uncommon for larger corporations to invest in promising healthcare companies, only to take advantage of their position by developing the underlying technology themselves or dispensing with the project so as to avoid cannibalizing sales.
Distressed venture finance and litigation finance are relatively new financial products that can help otherwise vulnerable businesses protect themselves. Companies, such as Lake Whillans, that provide these products can help businesses threatened by others' unscrupulous actions.
As much as the landscape for biotechnology startups has changed over the last decade, one thing that hasn’t changed is this: Intellectual property is the beating heart of a business.